Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpha-synuclein (Homo sapiens (Human)) | BDBM207889 (US9266832, Cpd046) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207891 (US9266832, Cpd048 | US9266832, Cpd084) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207875 (US9266832, Cpd032) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 14 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207874 (US9266832, Cpd031) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207920 (US9266832, Cpd077) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 17 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207896 (US9266832, Cpd053) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 17 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207923 (US9266832, Cpd080) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 18 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207895 (US9266832, Cpd052) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207882 (US9266832, Cpd039) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 22 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207888 (US9266832, Cpd045) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 22 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207924 (US9266832, Cpd081) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 23 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207950 (US9266832, Cpd107) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 26 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207891 (US9266832, Cpd048 | US9266832, Cpd084) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 26 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207942 (US9266832, Cpd099) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 27 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207919 (US9266832, Cpd076) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 29 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207918 (US9266832, Cpd075) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 30 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207881 (US9266832, Cpd038) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 31 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207885 (US9266832, Cpd042) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 31 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207892 (US9266832, Cpd049) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 31 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207876 (US9266832, Cpd033) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 31 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207880 (US9266832, Cpd037) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 32 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207898 (US9266832, Cpd055) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 36 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207879 (US9266832, Cpd036) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 40 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207897 (US9266832, Cpd054) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 42 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207943 (US9266832, Cpd100) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 44 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207945 (US9266832, Cpd102) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 49 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207893 (US9266832, Cpd050) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 50 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207887 (US9266832, Cpd044) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207926 (US9266832, Cpd083) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 56 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207878 (US9266832, Cpd035) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 60 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207877 (US9266832, Cpd034) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 62 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207890 (US9266832, Cpd047) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 65 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207902 (US9266832, Cpd059) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 68 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207899 (US9266832, Cpd056) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 70 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207958 (US9266832, Cpd115) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 75 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207935 (US9266832, Cpd092) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 76 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207853 (US9266832, Cpd010) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 78 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207884 (US9266832, Cpd041) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 80 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207922 (US9266832, Cpd079) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 81 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207949 (US9266832, Cpd106) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 82 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207869 (US9266832, Cpd026) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 83 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207872 (US9266832, Cpd029) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 84 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207904 (US9266832, Cpd061) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 86 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207912 (US9266832, Cpd069) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 90 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207933 (US9266832, Cpd090) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 91 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207866 (US9266832, Cpd023) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 94 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207873 (US9266832, Cpd030) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 96 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207932 (US9266832, Cpd089) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 98 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207883 (US9266832, Cpd040) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 103 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-synuclein (Homo sapiens (Human)) | BDBM207862 (US9266832, Cpd019) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 103 | n/a | n/a | n/a | n/a |
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent | Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen... | US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 90 total ) | Next | Last >> |